In vitro serological method of diagnosing infective...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/04 (2006.01) C12Q 1/00 (2006.01) G01N 33/569 (2006.01)

Patent

CA 2478529

The invention relates to an in vitro serological method of diagnosing infective endocarditis with negative hemoculture caused by Coxellia burnetii and Bartonella sp bacteria in a patient with a cardiac valve disorder. The inventive method is characterised in that it consists in: dosing IgG-type antibodies of the phase I Coxellia burnetii bacterium and IgG-type antibodies of a Bartonella sp bacterium onto one same serum of a patient, and determining if the titre of said IgG antibodies is greater than or equal to 1/800?th¿.

La présente invention est relative à une méthode de diagnostic sérologique in vitro des endocardites infectieuses à hémoculture négative causées par les bactéries Coxellia burnetii et Bartonella sp chez un malade atteint d'une affection des valves cardiaques, caractérisée en ce qu'on réalise un dosage des anticorps de type IgG de la bactérie Coxellia burnetii de phase I et des anticorps de type IgG d'une bactérie Bartonella sp, sur un même sérum d'un dit malade, et on détermine si le titre desdits anticorps IgG est supérieur ou égal à 1/800 ?ème¿.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

In vitro serological method of diagnosing infective... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with In vitro serological method of diagnosing infective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vitro serological method of diagnosing infective... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2026190

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.